Pharma VC Funds

Inveready, founded in 2008 and headquartered in Barcelona, is a prominent asset manager in Spain, specializing in various stages of venture capital, growth capital, venture debt, strategic public equity, private equity, and infrastructure investments. With over €1.2 billion in assets under management and a portfolio of 220 companies, Inveready has a strong track record of supporting innovative and high-growth ventures. The firm’s investment strategies span multiple sectors, including technology, biotech, fintech, medtech, and industrial technologies. Notable portfolio companies include Feedzai, which has achieved unicorn status, and several others that have been acquired by major multinationals such as Intel, Symantec, and Facebook, or have listed on major stock exchanges like Nasdaq and Euronext. Inveready typically invests between €500,000 and €5 million, supporting companies from early stages to growth and beyond. They have offices in San Sebastián, Madrid, and Barcelona, positioning them well to leverage opportunities across Europe and North America. Their unique approach combines traditional equity investments with innovative financing solutions like venture debt and tax lease structures, tailored to minimize dilution for founders while maximizing growth potential.

Invesco Private Capital, a division of Invesco, specializes in a broad range of investments, including early-stage ventures, growth capital, buyouts, and private equity. With over 25 years of experience, they leverage a deep network of industry relationships and extensive market insights to identify and support high-potential startups and emerging private equity managers​. Invesco’s notable investments span across various sectors, including technology, healthcare, and financial services. They have been involved in significant ventures and direct investments that align with their strategy of partnering with innovative and scalable companies. Their comprehensive approach includes not only capital investment but also strategic support and operational expertise to help portfolio companies achieve sustainable growth. For more information on their investment strategies and portfolio, you can visit the Invesco website or explore their detailed profiles on investment platforms like PitchBook and Crunchbase.

Investec, an Anglo-South African international banking and wealth management group, is recognized for its diverse investments and notable projects. The company operates globally, offering financial products and services to clients in Europe, Southern Africa, and the Asia-Pacific region. It is dual-listed on the London and Johannesburg Stock Exchanges. One of Investec's significant projects is its partnership with Proparco on the Transforming Financial Systems for Climate (TFSC) program. This initiative supports South Africa's transition to a low-carbon economy with an $80 million climate finance-dedicated credit facility aimed at expanding climate-related financing in the region. This project aligns with South Africa's goal to reduce carbon emissions by 42% by 2025 and diversify its electricity production away from coal by 2050. Investec has also been instrumental in financing renewable energy projects, such as the €72.5 million facility for WElink's 220MW Solara4 solar PV farm in Portugal, Europe's largest unsubsidized solar project. This project will provide sustainable energy to 200,000 homes and reduce carbon emissions significantly. Moreover, Investec's energy and infrastructure finance division has arranged over $11 billion in financing in North America over the past three years, demonstrating its expertise in conventional and renewable power, midstream oil and gas, transportation, and digital infrastructure. These initiatives highlight Investec's commitment to sustainability and its strategic focus on supporting large-scale renewable projects and climate-related investments globally.

Investible is a prominent early-stage venture capital firm based in Sydney and Singapore, focusing on investments in Australia, New Zealand, Southeast Asia, and globally. Established to support visionary founders, Investible targets pre-seed to Series A companies across various sectors, including fintech, martech, edtech, healthtech, and climate tech. The firm operates through several funds, including the $51.6 million Early-Stage Fund 2 and the Climate Tech Fund. They also have a unique investment syndicate called Club Investible, which includes over 150 members who invest alongside the firm's funds. This model allows Investible to offer comprehensive support, including capital, expertise, and an extensive network of advisors and industry connections. Investible's portfolio includes notable companies like Quantum Brilliance and Manetta's Seafood Market, highlighting their diverse investment strategy. They emphasize a founder-friendly approach, aiming to provide ongoing support as businesses grow, with check sizes typically ranging from AU$250,000 to AU$1.5 million.

IP Group is a leading FTSE-250 listed venture capital firm specializing in intellectual property commercialization. Notable for its deeptech focus, IP Group has been instrumental in developing over 300 companies, with significant investments in life sciences, cleantech, and cutting-edge technologies. High-profile portfolio companies include Oxford Nanopore Technologies, Centessa Pharmaceuticals, and Hinge Health. Geographically, IP Group maintains a strong presence in the UK, with partnerships across 17 UK universities and significant ties to institutions in the US, Australia, and New Zealand. The firm’s investment strategy emphasizes patient capital and long-term support, particularly in university spin-outs. IP Group invests at various stages, from seed to growth, and often continues funding as companies scale. This approach includes providing commercialization assistance, executive recruitment, and securing growth-stage capital from co-investors. The firm’s evergreen structure allows it to sustain the lengthy development cycles typical of deeptech ventures. Key team members include CEO Greg Smith and COO Alan Aubrey, who bring extensive expertise in technology transfer and IP management. IP Group typically leads investment rounds and prefers to be approached by startups with strong IP and technological differentiation. With an average check size of over £1.5m for VC rounds, the firm remains highly active, having invested £1bn in the first half of the current financial year. In summary, IP Group’s robust support system, extensive university partnerships, and strategic patience make it a cornerstone for deeptech and innovative startups looking to transform breakthrough ideas into commercial realities.

IQ Capital is a leading venture capital firm based in Cambridge, UK, specializing in deep tech investments. With over $1 billion in assets under management, IQ Capital targets seed to Series A stage startups across the UK and Europe, focusing on transformative technologies like AI, quantum computing, robotics, and synthetic biology. Notable investments include Grapeshot (acquired by Oracle), Bloomsbury AI (acquired by Facebook), and Thought Machine, a prominent cloud banking startup valued at $2.7 billion. IQ Capital's strategy emphasizes investing in IP-rich technologies with global market potential. Initial investments range from $2.5 million to $5 million, with follow-on investments reaching up to $15 million. The firm recently closed its fourth venture fund at $200 million to support deep tech companies from seed through growth stages. Key team members include co-founders Max Bautin and Kerry Baldwin, both with extensive experience in deep tech venture capital. The team has grown significantly, adding experts like Rick Hao and Daniel Carew, who bring diverse expertise across AI, cybersecurity, and advanced manufacturing.

IRIS Ventures is a growth equity firm focused on supporting visionary founders building consumer brands that prioritize health, wellness, and convenience. Launched in 2021, IRIS operates across Europe, the UK, and the US, investing in tech-enabled solutions that aim to make life healthier and more sustainable. The firm champions companies that embrace responsible innovation, transparency, and diversity, with a particular emphasis on long-term societal impact. Key brands in the IRIS Ventures portfolio include Saysh, the women’s athletic footwear company founded by Olympic athlete Allyson Felix; Artemest, a luxury marketplace that showcases Italian craftsmanship; and Vicio, a rapidly growing food delivery startup in Spain. Other investments, like Biomel, which offers plant-based gut health products, and Olistic, a wellness brand focused on hair care, reflect IRIS’s commitment to well-being and modern consumer needs. The firm’s investment approach is centered around empowering brands that resonate with today's consumers, helping them scale while fostering positive change. IRIS Ventures seeks out companies at the intersection of health, sustainability, and convenience, focusing on those that can drive both economic returns and social impact. Their mission is to back founders who are rewriting the future of consumer goods, with a strong belief that brands should not only deliver exceptional products but also contribute to a more inclusive and healthier world​.

IrishAngels is an angel investing network associated with the University of Notre Dame, focusing on pre-seed and seed stage startups. With a network of over 250 investors, IrishAngels has deployed more than $20 million in capital across various sectors including B2B, consumer, and medical companies. They provide substantial support through their active network, ensuring that companies receive not only financial backing but also strategic guidance and resources for growth. Notable investments in their portfolio include Elevate K-12, a platform providing live streaming online instruction; Genomenon, which offers a comprehensive source of genomic evidence; and Hallow, a Christian prayer app that provides guided religious content. They also have investments in technology-driven companies like Groupsense, which tracks cyber threats, and Fulcrum, which powers a connected manufacturing supply chain through machine learning. IrishAngels holds quarterly meetings, currently conducted remotely, providing investors with opportunities for networking and business development. The group emphasizes a collaborative and founder-friendly approach, maintaining regular check-ins to support portfolio companies.

Iron Wolf Capital is an early-stage venture capital firm based in Vilnius, Lithuania, and London, specializing in funding startups that focus on disruptive technologies with global potential. With a particular focus on deep tech, AI, SaaS, and IoT, Iron Wolf Capital invests in pre-seed to early growth companies. The firm typically invests between €250,000 and €2 million, helping to scale businesses that demonstrate innovative products, technology, or business models. Their portfolio spans diverse sectors, including companies like Millo, a smart blender startup; Litilit, a developer of high-end fiber lasers; and Rendin, a platform revolutionizing the home rental process. Iron Wolf Capital supports these companies not only financially but also by leveraging its team's deep entrepreneurial and financial experience, guiding startups through the complex stages of growth. Iron Wolf Capital’s roots in the Baltics, combined with a global outlook, enable them to focus on building bridges between local talent and international markets. The firm is known for its hands-on approach, providing strategic advice and access to a robust network of partners and experts to foster success. The firm also emphasizes ESG (Environmental, Social, Governance) principles, integrating sustainability into its investment strategies to ensure long-term value creation.

iSeed Ventures, founded in 2014, is a venture capital firm based in San Francisco, California, that focuses on seed-stage investments in sectors such as digital health, the Internet of Things (IoT), and consumer technology. The firm aims to support innovative startups with high growth potential and has a diverse portfolio of companies across various industries. Some of the notable investments by iSeed Ventures include 9am.health, a virtual diabetes clinic that secured $3.7 million in seed funding to provide better diabetes care in the U.S., and CoderSchool, an online coding education platform based in Vietnam, which raised $2.6 million in pre-Series A funding to expand its reach. Other significant investments include Jeff, a fintech company focused on lending, and AvalonMeta Ventures, which combines education and gaming. iSeed Ventures is known for its commitment to supporting early-stage startups through strategic investments and active mentorship. The firm typically makes investments with an average round size of $2 million and has been involved in various rounds annually, showcasing its active role in the venture capital ecosystem.

iSelect Fund is a St. Louis-based venture capital firm focusing on early-stage investments in sectors that have a profound global impact, such as agriculture, food, and healthcare. They invest in companies addressing critical challenges like sustainable food production, improved healthcare delivery, and innovations that enhance human health through better nutrition. iSelect’s portfolio includes over 60 companies, such as Harpe Bioherbicide and Kula Bio, which are tackling sustainability in agriculture through natural and biotechnological solutions. The firm operates with an evergreen fund structure, offering ongoing investment opportunities with low minimums, making venture capital more accessible to accredited investors. Their investment strategy revolves around a balanced, diversified portfolio approach, which allows them to spread risk while supporting transformative companies. iSelect focuses on startups that leverage data, technology, and science to drive innovation, particularly in the areas of food systems, agtech, and health tech. Their emphasis on impact investing means they are highly selective, looking for businesses with the potential for significant financial returns as well as positive societal outcomes. They typically avoid sectors like cannabis and direct-to-consumer models, and focus on companies that can create long-term, scalable change.

iSGS Investment Works, founded in 2014 and headquartered in Tokyo, Japan, is a venture capital firm that focuses on early to late-stage investments. They have a diverse portfolio, with 63 investments to date, primarily in technology-driven sectors such as artificial intelligence, fintech, and consumer products. Notable investments include companies like Startbahn, which focuses on blockchain technology for the art industry, and SOUNDRAW, an AI-driven music creation platform. They have had significant exits, such as ExaWizards and Unipos, highlighting their success in fostering growth in innovative companies. The firm is led by key figures including Makiko Sato, founder and representative partner, Kazuhito Goshima, CEO, and Kei Sugawara, CFO. Their team combines extensive experience in technology and finance to support their portfolio companies effectively.

Isomer Capital is a London-based venture capital firm that operates as a "fund of funds," primarily investing in early-stage European tech VCs. Founded by Joe Schorge, Isomer has built a reputation for backing some of Europe's leading venture firms like Seedcamp, Hoxton Ventures, and Entrepreneur First, giving it exposure to high-potential startups across various sectors. With over 70 VC firms and 29 unicorns in its portfolio, Isomer Capital focuses on identifying promising early-stage ventures across Europe. Notable investments include companies like UiPath, Deliveroo, and Wefox. Their strategy includes direct co-investments in top-performing startups when they are ready to scale, secondary investments, and a strong commitment to providing liquidity solutions to founders and early investors. Their latest fund, Isomer Capital III, targets €250 million, continuing their focus on European growth-stage startups. They plan to deploy this fund over the next few years, with key supporters such as British Business Investments and the European Commission.

Israel HealthCare Ventures (IHCV) is a leading Israeli life sciences venture capital fund founded in 2000 and based in Tel Aviv. The firm has raised two funds, IHCV I and IHCV II, cumulatively investing approximately $135 million across 27 companies in Israel-based startups. Founder and Managing Partner Hadar Ron leads the firm with a hands-on investment approach, preferring to hold board seats in portfolio companies and providing professional advice, ongoing management support, and access to a global network of medical and financial contacts. IHCV invests from seed to later stages across medical devices, biotechnology, pharmaceuticals, life sciences, nanotechnology, and medical-related IT. Approximately 75% of the portfolio consists of medical device companies, with the remaining 25% in pharmaceuticals and biotechnology. Investment checks are typically in the $3 million to $10 million range, and the firm leads rounds. The portfolio spans medical fields including cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, and central nervous system disorders, covering therapeutic and diagnostic technologies as well as rehabilitation, drug delivery, and consumer healthcare. Co-investors include Teva Pharmaceuticals. The portfolio has achieved 3 IPOs and 3 acquisitions. The most significant exit is Mazor Robotics, a surgical robotics company acquired by Medtronic for $1.7 billion in September 2018. Gamida Cell, a cell therapy company, completed its NASDAQ IPO in October 2018, raising $139 million in total. Xylo Technologies also achieved an IPO exit. Other notable companies in the portfolio include CorAssist, OrSense, and Optonol. IHCV's two-decade track record in Israeli life sciences reflects the firm's consistent focus on technology that addresses large patient populations with unmet clinical needs. The firm's extensive global medical network enables portfolio companies to access regulatory expertise, clinical partnerships, and commercial relationships across the United States, Europe, and Asia.

IST Cube is a venture capital fund based in Austria, focusing on science-based startups and academic spin-offs that are pioneering innovative solutions in deep tech and other high-impact sectors. Founded in partnership with the Institute of Science and Technology Austria (IST Austria), IST Cube is designed to help early-stage companies commercialize breakthrough technologies derived from academic research. The fund primarily targets investments in deep tech sectors such as IT, healthcare, energy, and advanced materials. With a typical investment range between €1 million and €2 million, IST Cube supports startups from pre-seed to later stages, with a strong focus on long-term development and growth. The firm is committed to backing companies that combine cutting-edge science with scalable business models. IST Cube provides its portfolio companies with more than just capital. The fund also offers strategic guidance, mentorship, and access to a broad network of industry experts and collaborators. Startups benefit from IST Cube's deep understanding of intellectual property, business development, and technology transfer, which helps founders navigate the complexities of scaling science-driven innovations. Some of IST Cube's notable investments include Prewave, an AI-driven supply chain monitoring platform, and contextflow, a company specializing in AI-powered medical imaging solutions. By bridging the gap between academic innovation and market application, IST Cube is fostering the next generation of groundbreaking technologies.

IT-Farm is a venture capital firm that focuses on early-stage technology startups with transformative potential. Founded in 1999, IT-Farm is based in Tokyo, Japan, and has expanded its reach to include investments in North America and Asia. The firm has a strong track record of supporting innovative companies in sectors such as IT, AI, IoT, and cleantech. Some notable startups in IT-Farm's portfolio include Plus One Robotics, which offers industrial robotics solutions for material handling in e-commerce, and TerraClear, an ag-tech company specializing in automated rock-picking solutions for agriculture. These investments highlight IT-Farm's commitment to backing companies that address significant industry challenges through advanced technology​. IT-Farm's investment strategy emphasizes hands-on support and strategic guidance, helping startups navigate early-stage development and scale their operations. The firm provides critical resources beyond capital, such as mentorship and connections to a global network of industry experts and potential partners. The team at IT-Farm includes experienced investors and industry veterans who bring a wealth of knowledge and expertise to their portfolio companies. This collaborative approach has been instrumental in fostering innovation and driving growth across various technology sectors.

IU Ventures is a 501(c)(3) affiliate of Indiana University focused on investing in and supporting early-stage, IU-affiliated startup companies, generating social and economic impact for the university, Indiana, and beyond. Founded in 1997 and based in Bloomington, Indiana, the organization is led by Tony Armstrong, President and CEO since 2008, and Jason Whitney, Chief Venture Officer and Executive Director, with a team of 28 members including 12 partners. IU Ventures manages three investment programs: the IU Angel Network, the $11 million IU Philanthropic Venture Fund established in 2018 as an evergreen fund, and the Innovate Indiana Fund established in 2010 and now fully invested. The firm leads rounds across pre-seed and seed stages, with checks from $100,000 to $1 million. The portfolio includes 68 companies across life sciences, health technology, enterprise software, fintech, and consumer sectors. IU Ventures focuses on Indiana University's traditional strengths in life and health sciences alongside emerging areas including engineering, cybersecurity, quantum computing, and big data analytics. The portfolio has achieved 1 IPO and 14 acquisitions. MBX Biosciences listed on NASDAQ in September 2024 at a $510 million market cap, the most notable exit. Other acquisitions include Sharpen, PrecisionHawk, Doxly, Encamp, Mentor Collective, Canopy, Probari, Diagnotes, and Qumulex. IU PhV portfolio companies include Confluence Pharmaceuticals, Nerx BioSciences, Scioto Biosciences, NuCurrent, Amplified Sciences, Boardable, MetaCX, and Monument Biosciences. The firm led a $1.9 million seed round of Adipo Therapeutics alongside VisionTech Partners and Elevate Ventures. The most recent investment was in Membershine in December 2025. IU Ventures has received the Mira Award for Investor of the Year for its commitment to investing in diverse founding teams. The organization's university affiliation gives it a direct pipeline to faculty-led spinouts, graduate student ventures, and commercialized research, creating a deal flow channel unavailable to conventional institutional funds.

JAM Fund, founded by Justin Mateen in 2020 and headquartered in Los Angeles, California, is a venture capital firm known for investing in visionary founders disrupting large markets. The firm focuses on early-stage investments, particularly in sectors such as fintech, e-commerce, SaaS, and consumer technology. JAM Fund has a portfolio of over 100 investments and has achieved notable exits including companies like Bueno Finance, COMPASS Pathways, and Rebate. Some of their recent investments include Rollup, Conta Simples, and Urbanic. JAM Fund often co-invests with other prominent venture capital firms like Y Combinator, Andreessen Horowitz, and Thiel Capital, enhancing their ability to support startups with substantial resources and networks. The firm leverages its founder's extensive network and experience to provide strategic guidance and operational support to its portfolio companies, helping them navigate growth and scale effectively. With a focus on high-potential early-stage companies, JAM Fund continues to make significant contributions to the startup ecosystem.

Jaza Rift Ventures is an impact investment firm founded in 2022 and based in Nairobi, Kenya, with additional offices in Accra, Ghana, and Luxembourg. Launched in partnership with Villgro Africa, the firm is exclusively focused on healthcare in Africa. The maiden Jaza Rift Pioneers Fund is a $5 million impact VC fund deploying checks of $100K to $500K at pre-seed, seed, and seed-extension stages into healthtech, medtech, and biotech founders across the continent. The firm also targets a larger $50 million fund for early-stage investments in digital health, medtech, and biotech. Jaza Rift leads rounds within its portfolio. The firm is a recognized Beyond The Billion partner. Managing Partner Sewu-Steve Tawia brings more than 20 years of experience in development finance, consulting, angel investing, and venture capital across Europe and Africa. Tawia holds CAIA and CIFE certifications and is an alumnus of London Business School, Audencia Business School, and Stanford GSB. The partnership with Villgro Africa provides access to a pipeline of more than 1,600 startups, with 20 identified as potential fund returners. Portfolio companies include Taneel (life and health insurance), Neopenda (medical devices for emerging markets), Plural Health (enterprise healthcare systems), and YeneHealth (Ethiopian femtech, where Jaza Rift led the pre-seed round in July 2023). Jaza Rift's thesis is straightforward: affordable, accessible, and high-quality healthcare in Africa represents both an urgent social need and a significant investment opportunity. The firm provides the '4Cs' framework alongside a network of advisors spanning biotech, medtech, and digital health to help portfolio founders navigate the unique challenges of building healthcare businesses across African markets.

Jazz Venture Partners, founded in 2015 and based in San Francisco, is a leading venture capital firm focusing on technologies that enhance human performance. They have a diverse portfolio that includes notable companies like Sounding Board, KLOWEN Braces, Robust.AI, AppliedVR, Pymetrics, Embodied, and Mahana Therapeutics. Their investment strategy is centered on early-stage startups, particularly at the pre-seed, seed, and Series A stages, and they focus heavily on sectors like EdTech, HR Tech, software, health and wellness, robotics, and AI/ML. Geographically, Jazz primarily invests in U.S.-based companies but maintains a global perspective. Their approach includes backing innovative companies that leverage cutting-edge neuroscience and digital technologies to push the boundaries of human potential. They have successfully exited several investments, including Akili Interactive, which went public, and Pymetrics, acquired in 2022. Jazz Venture Partners typically writes checks in the range of $500K to $3M and is open to connecting with startups through their extensive network. They build their investment funnel through a combination of proactive scouting and leveraging their robust network in the tech and science communities​.

Jeito Capital is a global private equity fund specializing in life sciences, with a strong focus on biopharma companies. Founded in Paris, Jeito supports breakthrough innovations that address critical unmet medical needs. The fund's mission is centered on improving patient outcomes through targeted investments in early-stage and growth-stage biopharma companies, particularly those working on therapies for life-threatening diseases. Jeito operates with a unique long-term investment strategy, providing continuous financial support from clinical development through to market access. This allows its portfolio companies to achieve significant milestones while accelerating drug development. The fund has a diverse portfolio of companies, including SparingVision, which is developing gene therapy treatments for inherited retinal diseases, and CatalYm, a biopharma firm working on novel cancer immunotherapies. With over €534 million under management, Jeito's integrated team of experts spans the entire drug development value chain, offering portfolio companies not only capital but also strategic guidance in areas like regulatory affairs, clinical trials, and commercialization. Jeito’s investment approach is also distinguished by its emphasis on global impact, working across Europe and the United States to bring life-saving treatments to market. Jeito has rapidly become a significant player in the life sciences sector, driven by its patient-centered philosophy and focus on fostering the growth of biotech companies that are on the cutting edge of medical innovation.

Jerusalem Venture Partners (JVP), founded in 1993 by Dr. Erel Margalit, is a leading international venture capital firm headquartered in Jerusalem, with additional offices in New York, Tel Aviv, and Be’er Sheva. The firm focuses on early to growth-stage investments across various sectors including cybersecurity, big data, fintech, foodtech, and digital health. Notable investments by JVP include CyberArk, QlikTech, and Earnix. CyberArk is renowned for its cybersecurity solutions and went public on NASDAQ. QlikTech, a cloud-based business intelligence platform, also had a successful NASDAQ IPO. Earnix, which provides AI-based analytics solutions for insurers and banks, achieved unicorn status with its significant valuation. JVP has raised over $1.4 billion across multiple funds and has a strong track record of successful exits. The firm supports its portfolio companies through the Margalit Startup City model, which offers office space, management support, and strategic guidance in dynamic creative campuses located in Jerusalem and New York. These centers foster innovation and collaboration among startups, entrepreneurs, and strategic partners​.

Johnson & Johnson Innovation is a global network dedicated to empowering healthcare innovators. Founded in 2012, JLABS supports early-stage companies in the pharmaceutical, medical device, consumer, and health tech sectors. Their mission is to foster the development of life-saving and life-enhancing health solutions. JLABS operates across multiple locations, including San Diego, San Francisco, Cambridge, Shanghai, and New York. They offer a robust infrastructure and resources to startups, facilitating collaboration and growth. The initiative has made over 400 investments, including notable companies such as Capstan Therapeutics and Synthis Therapeutics, focusing on biotechnology and medical devices. Their investment strategy emphasizes strategic partnerships and co-investments, working alongside various industry leaders and funding bodies to maximize impact. Recent investments include support for companies like Immunyx, Grapheal, and Neurogene, showcasing their commitment to advancing innovative healthcare solutions.

JME Venture Capital, established in 2009, is a prominent venture capital firm based in Madrid, Spain. It focuses on early-stage technology startups, investing primarily in Spanish companies with notable expansions across Europe and occasional investments in the US. The firm has raised three funds with over €120 million in assets under management (AUM), investing between €100k and €3m per deal. JME's investment portfolio includes successful companies like Flywire, Jobandtalent, and Voi. Their investment strategy targets sectors such as fintech, healthtech, and blockchain technology. Notably, JME has invested in over 70 startups, leading to significant exits including companies like Volava and Waynabox. The team at JME Venture Capital is led by Samuel Gil and Javier Alarcó, who emphasize a fast and transparent investment process. They support founders with global-scale resources while allowing them to maintain control over their vision and operations​.

Jolt Capital is a Paris-based private equity firm specializing in growth-stage investments in deeptech companies across Europe. Founded in 2011, Jolt focuses on supporting technology-rich firms with strong fundamentals, particularly in sectors like photonics, advanced materials, semiconductors, artificial intelligence, and IoT. They typically invest between €10 million and €50 million in businesses that are poised for significant scale, offering both capital and operational expertise to help them expand globally. Jolt Capital stands out by using its proprietary AI platform, Jolt.Ninja, to identify promising investment opportunities. This technology-driven approach allows the firm to discover high-potential companies while avoiding market hype. Their portfolio includes notable companies like Heptagon, NIL Technology, and Verimatrix, all of which leverage cutting-edge technology to address significant market needs. The team at Jolt Capital combines decades of experience in technology, investment, and entrepreneurship, working hands-on with portfolio companies to assist in everything from business strategy to talent acquisition and financial optimization. With a focus on sustainable and responsible investment, Jolt Capital’s mission is to grow European deeptech firms that can transform industries and improve societal outcomes.

Joyance Partners, established in 2017, is a venture capital firm based in San Francisco, California. The firm focuses on investing in early-stage companies that use science and technology to cultivate joy, aiming to improve the way we live. Joyance Partners has made significant investments in health and consumer sectors, targeting companies from pre-seed to Series A stages across North America, Europe, and Asia. Their notable investments include ClosedLoop, which uses AI to identify at-risk patients and recommend interventions, and Copper Cow Coffee, which delivers a premium Vietnamese coffee experience. Another standout is Cubby, which creates smart beds designed to improve anxiety, sleep, and safety for individuals with cognitive disabilities such as Autism and Epilepsy. Joyance Partners also backs innovative companies in beauty and sustainability, like Conserving Beauty, which focuses on solutions-based skincare, and Electric Era, which works on sustainable energy solutions. The firm has made over 500 investments and boasts more than 200 exits, reflecting a strong track record in nurturing and scaling startups. They support companies that promise to enhance personal health, happiness, and well-being through technological advancements. The leadership team, including Managing Partner Michael Edelhart and Founding Partner William Lohse, leverages their extensive experience to guide their portfolio companies towards growth and success. Joyance Partners continues to be an influential player in the venture capital landscape, dedicated to investing in transformative technologies that bring joy to people's lives​.

JSR Corporation, headquartered in Tokyo, Japan, is a multinational company specializing in digital solutions, life sciences, and elastomers. Founded in 1957, JSR initially focused on synthetic rubbers but has since expanded its operations to become a leading global supplier in various technology-driven markets. One of JSR's major areas of expertise is semiconductor materials, where they produce lithography materials, CMP materials, and packaging solutions essential for semiconductor chip production. The company has also made significant strides in the life sciences sector, providing services and materials for drug discovery, diagnostics, and bioprocessing. They acquired companies like KBI Biopharma and Selexis to strengthen their capabilities in this field. JSR is also heavily involved in advanced semiconductor technologies. They acquired Inpria Corporation, a leader in metal oxide photoresist technology for extreme ultraviolet (EUV) lithography, to bolster their semiconductor materials portfolio. This acquisition aligns with JSR's strategy to enhance their presence in advanced semiconductor manufacturing processes. Moreover, JSR collaborates with Cambridge Quantum Computing (CQC) on quantum computing projects to develop state-of-the-art quantum algorithms. This partnership highlights JSR's commitment to staying at the forefront of technological innovation. Overall, JSR Corporation leverages its extensive R&D capabilities and strategic acquisitions to maintain its leadership in the semiconductor and life sciences industries, continuously driving innovation and value creation for its global customers.

K Fund is a venture capital firm based in Madrid, Spain, focused on backing tech-driven startups across Southern Europe and Latin America. Founded in 2016, K Fund invests from pre-seed to Series B stages, with check sizes ranging from €100K to €10 million. Their mission is to support visionary, unconventional entrepreneurs who are building scalable, technology-based solutions. The firm’s portfolio includes successful ventures such as Factorial, Exoticca, Voicemod, and Urbanitae, reflecting a diverse range of sectors including SaaS, fintech, travel, and AI. K Fund recently expanded its global footprint by establishing a local presence in São Paulo, Brazil, through their Leadwind fund. This initiative, launched with strategic partners like Telefónica and BBVA, targets deep tech scaleups and aims to bridge the startup ecosystems of Southern Europe and Latin America. Leadwind focuses on sectors like AI, IoT, and blockchain, with the goal of fostering collaboration between these two regions. The fund plans to raise €250 million, making investments starting at €5 million, to help scale these innovative businesses globally. K Fund also emphasizes ESG principles, recently publishing their first impact report, and has committed to promoting sustainability and diversity within their portfolio. Led by a team of seasoned professionals including Miguel Arias and Gustavo S. Carvalhal Ribas, K Fund continues to grow its influence, supporting startups that aim to disrupt traditional markets with cutting-edge technology and scalable business models.

K5 Global is a venture capital firm and incubation studio founded in 2018 by Michael Kives and Bryan Baum. Based in San Francisco, the firm supports founders throughout the entire business lifecycle, from seed stages to IPOs. K5 Global has deployed over $1.1 billion in capital and has made 174 direct investments, resulting in 11 exits. Their portfolio includes high-profile companies such as SpaceX, Uber, Coinbase, Lyft, and The Boring Company. K5 Global focuses on a wide array of industries, including enterprise SaaS, vertical SaaS, fintech, and consumer products. Some notable investments and launched companies include 818 Tequila, Parrot, and The Expert. The firm leverages its extensive network to help innovative companies expand and achieve their growth targets. The management team, led by Michael Kives and Bryan Baum, brings a wealth of experience from various sectors, ensuring robust support for their portfolio companies. K5 Global continues to make significant investments in cutting-edge technologies and groundbreaking startups​.

K50 Ventures, established in 2017 and headquartered in New York, is a venture capital firm dedicated to funding purpose-driven companies at the pre-seed and seed stages. The firm focuses on startups that aim to improve access and affordability in health, finance, and work for the global working class. Notable investments include Mammoth Biosciences, a pioneer in CRISPR technology; Groww, a mobile investing platform in India; and Midi Health, providing specialized healthcare for women over 40. K50 Ventures supports companies that democratize access to financial services, improve healthcare delivery, and empower small businesses and independent workers. Led by founders Ryan Bloomer and Adriel Bercow, K50 Ventures is committed to being the first institutional check and a long-term partner to mission-driven entrepreneurs. They seek founders with a clear vision for creating significant social impact and a solid strategy for execution.

Kairos HQ, founded in 2008 by Ankur Jain, is a venture capital firm based in New York City. Initially launched as The Kairos Society, it aimed to address significant global challenges through innovation. The firm focuses on early to mid-stage investments in healthcare, financial services, and consumer goods sectors, emphasizing affordability and simplicity in everyday life​. Notable investments include Bilt Rewards, a program allowing renters to earn points with rent payments, and Clair, which raised $25 million in its Series A round in July 2023. Other significant investments are Cera Care, a UK-based homecare service, and Alloy Health, a company focused on menopause health. Kairos HQ's strategy leverages its extensive network and expertise in building companies that tackle real-world problems. They manage around $300 million in assets, investing in startups that aim to improve housing affordability and personal health. The leadership team includes Co-CEOs Ankur Jain and Alex Fiance, and they emphasize a hands-on approach to nurturing their portfolio companies, providing strategic guidance and operational support to drive growth and success​.

Kairos Ventures, established in 2015 and headquartered in Beverly Hills, California, is a venture capital firm focused on investing in early-stage companies across life sciences, physical sciences, and technology sectors. The firm partners with leading scientists and universities to commercialize groundbreaking discoveries. Their portfolio includes notable companies like MemVerge, which aims to merge computer memory and storage using non-volatile RAM, and Neuro-Bio, a biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Another significant investment is MixComm, a developer of advanced 5G mmWave chips that enhance the efficiency and range of 5G base stations, which was acquired by Sivers Semiconductors in 2022. Kairos Ventures has made over 81 investments and achieved several exits, including Actinobac Biomed and MixComm. The firm is led by founder and CEO James Demetriades, along with a team of experienced professionals who provide strategic support to their portfolio companies.

Kaiser Permanente Ventures (KP Ventures) is a leading venture capital firm dedicated to investing in innovative healthcare solutions. Founded in 1998, KP Ventures has over $500 million in assets under management and focuses on areas such as health information technology, digital health, medical devices, diagnostics, and precision medicine. KP Ventures recently closed its fifth fund at $141 million, which includes contributions from Kaiser Permanente as well as other strategic investors like Tufts Health Plan, Henry Ford Health System, and Highmark Ventures. The firm's investment strategy aims to support companies that address significant unmet needs in the healthcare system, particularly those that align with Kaiser Permanente's mission of providing high-quality, affordable, and accessible care​. Some notable companies in their portfolio include iRhythm, Health Catalyst, and Omada Health. KP Ventures leverages its deep connections with Kaiser Permanente and other healthcare leaders to help its portfolio companies navigate and thrive in the complex healthcare landscape. The team at KP Ventures comprises experienced professionals like Cindy Vanderlinde-Kopper, Amy Belt Raimundo, and co-founders Chris Grant and Chris Stenzel, who bring extensive expertise in healthcare and venture investing.

Kapor Capital, based in Oakland, California, is renowned for its commitment to investing in early-stage tech startups that drive social impact and economic equity. Their portfolio includes notable startups like Bitly, Life360, and AngelList, reflecting their diverse investment range across sectors such as education, health, finance, and justice. Kapor Capital specifically targets tech-driven ventures that aim to close gaps in access for low-income communities and communities of color. Geographically, Kapor Capital focuses primarily on the United States, with a significant presence in the Bay Area. Their investment strategy emphasizes backing founders who leverage their lived experiences to address real community needs. The firm has a robust investment strategy, often leading funding rounds with average check sizes typically between $500,000 and $1 million. They are known for their active involvement in their portfolio companies, providing extensive support beyond capital, including strategic guidance and fostering a dynamic ecosystem for innovation. The fund prides itself on a rigorous commitment to diversity, with a significant portion of their investments going to companies with underrepresented and women founders. In 2023 alone, they deployed $10.7 million across 19 companies, demonstrating their active investment approach. Founders can approach Kapor Capital through their Platform team, which curates events and builds networks to support portfolio companies. Key team members include Mitch Kapor and Freada Kapor Klein, who bring decades of experience in tech and social impact investing. Their leadership has been pivotal in shaping the firm’s mission-driven approach. With a deep commitment to creating a fairer society, Kapor Capital continues to lead the way in impact investing.

Karista is an early-stage venture capital firm based in Paris, specializing in Health, Digital, Technology, and NewSpace sectors. Founded in 2001, the firm has backed over 100 companies, providing more than just financial support. Karista is known for its hands-on approach, helping startups with team structuring, business development, and strategic guidance. Notable investments include Exotrail, a company developing agile space mobility solutions, and Incepto, which raised €27M for its digital health platform. Karista typically invests between €500k and €2.5M in seed and Series A rounds, with follow-on investments up to €6M. They often take board seats to offer deep involvement in the companies they support. Karista's strategy emphasizes early investment in innovative projects with strong value propositions. They co-create with founders, ensuring alignment in vision and goals. The firm manages several funds, including the Paris Region Venture Fund and the SpaceTech fund, focusing on companies ready to impact their markets and improve user lives.

Korea Biomedical Industry Development Institute (KBIC) is a pivotal entity in South Korea's life sciences and biomedical sectors. Established to stimulate innovation and economic growth, KBIC supports a wide range of activities in medical, pharmaceutical, and biological fields, focusing on advanced technologies like AI and regenerative medicine. KBIC operates through various initiatives and partnerships to foster a robust ecosystem for biomedical research and development. Key areas of focus include promoting bio-health exports, enhancing R&D capabilities, and nurturing talent within the bio-health industry. The South Korean government provides substantial funding and regulatory support to boost the global competitiveness of Korean bio-pharma companies. The institute emphasizes international collaboration, participating in global conventions and establishing partnerships with leading research institutions and biopharmaceutical companies worldwide. This approach enhances innovation and facilitates the entry of Korean companies into the global market.

Koch Disruptive Technologies is a venture capital firm within Koch Industries, focused on investing in transformative companies across various stages and industries. KDT partners with innovative companies that leverage advanced technologies to create significant economic and societal impacts. The firm’s investment strategy is sector-agnostic, including notable areas like biotechnology, health tech, agriculture, and AI. Some prominent companies in their portfolio include PathAI, which improves pathology diagnostics using AI, and Solugen, which creates environmentally-friendly chemicals through enzymatic reactions. Other investments include Terray Therapeutics, focusing on novel treatments for human diseases, and Andes, which develops bio-based agricultural solutions to enhance crop production. KDT provides more than just financial backing. They offer strategic guidance and leverage Koch Industries’ extensive network to help portfolio companies scale and succeed. The team at KDT includes professionals with diverse expertise, providing valuable support in navigating market challenges and accelerating growth.

Keen Venture Partners is a venture capital firm based in Amsterdam and London, focusing on early-stage investments in European technology companies. Founded in 2014, the firm is known for its "radically human" approach, emphasizing strong partnerships with exceptional founders to support their growth journey. Keen typically invests in Series A and B rounds, with ticket sizes ranging from €5 million to €10 million. Their portfolio includes companies like Beekeeper, Crisp, Farewill, and Rescale. The firm targets various sectors, including infra-tech, vertical SaaS, climate tech, productive AI & data, marketplaces, and frontier tech. The team at Keen Venture Partners comprises experienced professionals who have built and scaled companies themselves, providing valuable insights and support to their portfolio companies. They prioritize working with founders who have a clear vision and the ability to build and lead strong teams.

Kenetic Capital is a Hong Kong-based venture capital firm that focuses on early-stage investments in blockchain and cryptocurrency technologies. Established in 2016, the firm is dedicated to backing projects that build blockchain infrastructure, data solutions, enterprise tools, trading platforms, and financial services. Kenetic’s goal is to support the next generation of technologies that will drive mass adoption of blockchain, targeting institutional and enterprise use cases. With a global portfolio, Kenetic has made over 130 investments across key regions, including the United States, United Kingdom, China, and Singapore. Notable investments include Alchemy, Blockdaemon, and Boba Network, which are key players in blockchain infrastructure and decentralized applications. Kenetic is highly active in the blockchain space, with investments in emerging Web3 projects like Immutable X, Worldcoin, and Flare, all of which have delivered significant returns​. Kenetic also partners with leading blockchain funds and co-investors, such as NGC Ventures and Fenbushi Capital, strengthening its position as a major player in the blockchain ecosystem.

Keystone Capital is an entrepreneurial holding company and private equity firm founded in 1994 by Kent Dauten and Scott Gwilliam. Based in Chicago, Illinois, Keystone has historically utilized the personal capital of its partners to acquire high-quality, market-leading businesses. In 2021, the firm closed its debut institutional fund, Keystone Capital Fund II, LP, with $420 million in capital commitments, marking a significant evolution in its strategy by including external investors. Keystone Capital focuses on long-term value creation by acquiring and growing businesses across various sectors, including engineering and technical services, tech-enabled services, commercial services and engineered products, and food and beverage manufacturing. The firm emphasizes operational and growth-oriented support for business owners and management teams, aiming for sustainable success. Keystone’s investment philosophy is built on three core values: expertise, conservative investing, and creativity. They conduct thorough preliminary tests to ensure profitability and optimal risk diversification in each transaction, maintain a controlled risk approach to provide investor confidence, and employ creative thinking to overcome barriers and execute complex deals. The firm's recent investments include partnerships with Inspire11 and ClearWater Solutions. Keystone has completed over 110 acquisitions throughout its history and continues to actively manage and grow its portfolio, recently completing ten add-on acquisitions and selling two platform investments in late 2020.

Khosla Ventures, founded by Vinod Khosla in 2004, is a prominent venture capital firm based in Menlo Park, California. The firm is renowned for its investments in early-stage companies across various sectors including internet, computing, mobile, financial services, agriculture, healthcare, and clean technology. Notable investments by Khosla Ventures include high-profile companies like DoorDash, Square, Impossible Foods, Stripe, OpenAI, Instacart, and Nutanix. These companies have not only achieved significant market success but also driven innovation in their respective fields​. Khosla Ventures is known for its willingness to take bold, contrarian bets on groundbreaking ideas. This approach has led to investments in companies that challenge established business models and drive significant industry changes. The firm operates two main funds: a seed fund focused on experimental science and innovation, and a main fund for more traditional ventures from early to later stages. The firm's founder, Vinod Khosla, emphasizes a hands-on approach in supporting entrepreneurs, offering not just capital but also strategic guidance and operational support. This philosophy has made Khosla Ventures a preferred partner for visionary founders looking to make a substantial impact​.

Khwarizmi Ventures, founded in 2018, is a Riyadh-based venture capital firm that invests in early-stage startups across the MENA region. With a strong commitment to supporting innovative founders, the firm manages a $70 million fund and has built a portfolio of over 50 companies across sectors such as fintech, e-commerce, digital health, and proptech. Some of the standout companies in their portfolio include Tamara, a fintech startup, and Eyewa, a leading e-commerce platform for eyewear. Khwarizmi Ventures also boasts notable exits like POSRocket and Fatura, which have further cemented its role as a key player in the region's startup ecosystem. The firm prides itself on an entrepreneur-centric approach, going beyond capital by offering strategic support and leveraging its vast network of regional and global partners to help startups scale. They focus on fast-tracking deals, often leading funding rounds and closing within three to four months, enabling founders to focus on their core business operations. With investments across eight countries, Khwarizmi Ventures plays an instrumental role in empowering startups to achieve regional and global success​. Khwarizmi Ventures’ mission is to partner with exceptional entrepreneurs who are solving complex problems in the ever-evolving markets of the Middle East, North Africa, and Pakistan (MENAP), making it one of the most dynamic VC firms driving innovation in the region.

Kickstart Fund, established in 2008 and headquartered in Cottonwood Heights, Utah, focuses on early-stage investments in the Mountain West region, including Utah and Colorado. The firm has a diverse portfolio with notable investments in companies like Spiff, Artemis Health, and Grow. They primarily invest in sectors such as SaaS, consumer, marketplace, and healthcare, with an emphasis on technology-driven startups. The fund's investment strategy includes leading and participating in pre-seed, seed, and Series A rounds, typically writing initial checks between $250,000 and $1 million. They prioritize companies with strong growth potential and innovative solutions in large markets. Kickstart is known for providing not just capital but also a connected community and expert guidance to help startups scale. Key team members include founder Gavin Christensen, General Partners Dalton Wright and Kat Kennedy, and CFO Alex Soffe, all based in Utah. The team brings a wealth of experience and a hands-on approach to supporting their portfolio companies through operational strategy, networking, and mentorship. Kickstart has demonstrated a strong track record with successful exits, including Cotopaxi and Degreed, highlighting their capability to identify and nurture high-potential startups. Entrepreneurs looking to partner with Kickstart should focus on showcasing their innovative solutions and market potential, aligning with the fund's commitment to driving growth in the Mountain West region​.

Killick Capital, founded in 2004 and headquartered in St. John's, Newfoundland, is a private equity firm that invests in technology-driven startups with high growth potential. Their focus sectors include technology, aerospace, and Newfoundland & Labrador businesses. Notable investments by Killick Capital include PathFactory, Sequence Bio, and Swiftsure Innovations. They have also successfully exited from companies like Postmates and Deliv. The firm is led by Mark Dobbin, who provides capital and strategic support to portfolio companies. Killick Aerospace Fund and Killick Newfoundland & Labrador Fund are key components of their investment strategy, supporting companies in these regions with significant growth potential.

Kima Ventures, established in 2010 by Xavier Niel, is one of the world's most active early-stage investment funds, based in Paris, France. The firm is renowned for its prolific investment pace, funding 2-3 startups per week globally, totaling over 800 investments to date. Kima Ventures provides $150,000 in seed funding to early-stage startups across various sectors, including software, fintech, healthcare, and consumer products. Their portfolio includes notable companies like Wise, Front, and Oyster, and they have achieved 17 unicorns and 111 exits. Kima Ventures supports founders with funding, a robust network, and strategic guidance to accelerate their growth. Key team members include Xavier Niel and Jean De la Rochebrochard, who bring extensive experience and expertise in the tech and startup ecosystems. Kima Ventures' approach is characterized by its rapid decision-making process and a strong commitment to backing innovative and disruptive startups globally. For entrepreneurs, Kima Ventures is an attractive partner due to their extensive experience, active investment approach, and strong support network, which significantly boosts the chances of success for early-stage companies.

Kindred Capital is a London-based venture capital firm that uniquely operates under an "equitable venture" model, where every founder they back becomes a co-owner of the fund. Founded in 2015, Kindred Capital focuses on mission-driven pre-seed and seed-stage investments across Europe and Israel. Their first fund has seen significant success, with 54% of portfolio companies raising Series A funding within three years, a stark contrast to the typical 19% industry average. Notable investments from Kindred Capital include companies like Five, which develops autonomous vehicle software, Paddle, a software sales platform, and Pollen, a marketplace for experiences and travel. They have also recently invested in startups such as BotsAndUs, which focuses on robotics, and Gravity Sketch, a 3D design platform. Kindred's equitable venture model is designed to foster a strong sense of community among founders, encouraging them to support each other. This approach has been well-received, with significant oversubscription in their funds and plans to continue this model with future investments. Their commitment to transparency, speed, and building robust networks around founders is central to their investment strategy.

Kinnevik is a leading investment company founded in 1936, known for its focus on digital consumer businesses. The firm primarily invests in healthcare, software, marketplaces, and climate tech, partnering with innovative entrepreneurs to drive change and improve the way we work, live, and play. Kinnevik’s portfolio includes over 30 companies, such as Cityblock, Mews, Pleo, and Recursion. Kinnevik operates with a long-term investment horizon, providing substantial support to its portfolio companies from early-stage to growth-phase. The firm emphasizes sustainability and believes in investing in business models that generate significant returns while promoting environmental and social responsibility. The executive team is led by CEO Georgi Ganev, with Samuel Sjöström recently appointed as Chief Strategy Officer. The team includes professionals with deep expertise across various sectors, dedicated to fostering the growth of pioneering companies. Kinnevik's investment approach combines financial backing with active involvement in the strategic direction of its portfolio companies, leveraging nearly a century of investment expertise to build successful, sustainable businesses.

K5 Global is a venture capital firm and incubation studio founded in 2018 by Michael Kives and Bryan Baum. Based in San Francisco, the firm supports founders throughout the entire business lifecycle, from seed stages to IPOs. K5 Global has deployed over $1.1 billion in capital and has made 174 direct investments, resulting in 11 exits. Their portfolio includes high-profile companies such as SpaceX, Uber, Coinbase, Lyft, and The Boring Company. K5 Global focuses on a wide array of industries, including enterprise SaaS, vertical SaaS, fintech, and consumer products. Some notable investments and launched companies include 818 Tequila, Parrot, and The Expert. The firm leverages its extensive network to help innovative companies expand and achieve their growth targets. The management team, led by Michael Kives and Bryan Baum, brings a wealth of experience from various sectors, ensuring robust support for their portfolio companies. K5 Global continues to make significant investments in cutting-edge technologies and groundbreaking startups.

Kizoo Technology Capital is a venture capital firm based in Karlsruhe, Germany, founded in 1999 by Michael Greve, Frank Schueler, and Matthias Hornberger. Part of the Mira Holding group alongside sister organization Forever Healthy Foundation, the firm manages a fund of approximately $349 million and has made 54 investments over its history. Kizoo now focuses exclusively on rejuvenation and longevity biotech, backing never-done-before technologies aimed at extending healthy human lifespans by addressing the root causes of aging. Patrick Burgermeister serves as Partner. The firm leads rounds and typically invests at the Seed and Series A stages, with check sizes ranging from $1 million to $10 million. Current active portfolio companies tackle age-related cellular damage from multiple angles: Cellvie (a Harvard spin-off developing mitochondria transfer therapy), Reservoir Neuroscience (brain vascular rejuvenation, $4 million financing in 2024), Cyclarity (arterial plaque removal), Elastrin (tissue decalcification), Revel Pharmaceuticals (collagen crosslink breakers, Yale-originated), and MoglingBio (stem cell rejuvenation). Many of these companies were seeded directly from university research at SENS lab, Yale, Harvard, Clemson, and UC Berkeley. Kizoo's legacy internet and SaaS portfolio includes early seed investments in several German unicorns — Staffbase, Mambu, and Babbel — though the firm no longer makes new investments in those sectors. Kizoo's approach is thesis-driven and deeply hands-on: the team partners with academic founders to help create companies from scratch, often before commercial infrastructure exists. The firm invests across Europe and the United States, reflecting the global nature of longevity science. Three portfolio companies have been acquired, most recently Shyftplan, which was acquired by Maguar in June 2024.

Kjøller is a Danish-founded investment company led by Magnus Kjøller, with its headquarters in Dubai. The firm focuses on two primary areas: venture investments and real estate. Kjøller is deeply involved in both startups and more mature companies, helping them scale and reach their full potential. The company prides itself on providing more than just capital, offering strategic advice, legal support, and networking opportunities to its portfolio companies. Since its inception, Kjøller has invested in over 75 startups worldwide, with 39 active venture investments currently in its portfolio. These investments span various industries, including fintech, e-commerce, media, and greentech, and are primarily focused in Europe and Asia. Some of its notable investments include Digura, Vikings Tech Group, and Kompasbank. Kjøller operates on a lean structure, allowing quick decision-making without the need for external approvals. The company’s approach is rooted in providing direct investments without fees, ensuring a straightforward process for both investors and entrepreneurs. Investors can join the Kjøller Investor List to participate in the firm's deal flow. Overall, Kjøller continues to be a prominent player in the venture capital space, known for its hands-on approach and a broad network that helps startups scale rapidly.